Result Summaries: GSK2245840
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| 114296 | phase 2 | A Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects with Moderate to Severe Plaque-Type Psoriasis (0 citation(s)) |  |